Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Study links testosterone to endometrial cancer:

This article was originally published in Clinica

Executive Summary

Dutch researchers have found evidence of a link between testosterone and endometrial cancer. Reporting their findings to the European Society of Human Reproduction and Embryology in Bologna, Italy, this week, the researchers said that compared with women with benign gynaecological conditions, patients with endometrial cancer had higher testosterone levels in blood vessels of the uterus and ovaries and higher expression of androgen receptors on endometrial cells. Lead investigator Dr Helen Mertens, of the Academic Hospital in Maastricht, speculated that the discovery could lead to improved treatments for endometrial cancer.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT076546

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel